中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
5期
27-28
,共2页
临床药师%临床路径%毛细支气管炎
臨床藥師%臨床路徑%毛細支氣管炎
림상약사%림상로경%모세지기관염
Clinical pharmacist%Clinical pathway%Capillary bronchitis
目的:探讨临床药师参与“毛细支气管炎”临床路径实施的方法和效果。方法临床药师参与临床路径制定后,回顾性分析我院临床路径实施前后第一诊断为“毛细支气管炎”患儿病历,比较临床路径实施前与临床路径实施后的患儿抗菌药物使用情况、住院费用,药品费用,住院天数,探讨临床药师参与临床路径的方法及效果。结果临床路径实施前后,患儿使用抗菌药物情况之间有统计学差异(P<0.01);患者住院总费用、药品费用和住院天数之间有统计学差异(P<0.01或P<0.05),临床路径实施后,患者的住院总费用、药品费用和住院天数都明显减少。结论临床药师参与临床路径制定,规范了患者用药,节约了住院费用和药品费用,缩短了住院天数,对节约治疗成本,切实减轻患者经济负担有重要的意义。
目的:探討臨床藥師參與“毛細支氣管炎”臨床路徑實施的方法和效果。方法臨床藥師參與臨床路徑製定後,迴顧性分析我院臨床路徑實施前後第一診斷為“毛細支氣管炎”患兒病歷,比較臨床路徑實施前與臨床路徑實施後的患兒抗菌藥物使用情況、住院費用,藥品費用,住院天數,探討臨床藥師參與臨床路徑的方法及效果。結果臨床路徑實施前後,患兒使用抗菌藥物情況之間有統計學差異(P<0.01);患者住院總費用、藥品費用和住院天數之間有統計學差異(P<0.01或P<0.05),臨床路徑實施後,患者的住院總費用、藥品費用和住院天數都明顯減少。結論臨床藥師參與臨床路徑製定,規範瞭患者用藥,節約瞭住院費用和藥品費用,縮短瞭住院天數,對節約治療成本,切實減輕患者經濟負擔有重要的意義。
목적:탐토림상약사삼여“모세지기관염”림상로경실시적방법화효과。방법림상약사삼여림상로경제정후,회고성분석아원림상로경실시전후제일진단위“모세지기관염”환인병력,비교림상로경실시전여림상로경실시후적환인항균약물사용정황、주원비용,약품비용,주원천수,탐토림상약사삼여림상로경적방법급효과。결과림상로경실시전후,환인사용항균약물정황지간유통계학차이(P<0.01);환자주원총비용、약품비용화주원천수지간유통계학차이(P<0.01혹P<0.05),림상로경실시후,환자적주원총비용、약품비용화주원천수도명현감소。결론림상약사삼여림상로경제정,규범료환자용약,절약료주원비용화약품비용,축단료주원천수,대절약치료성본,절실감경환자경제부담유중요적의의。
Objective To discuss the way and the effect of clinical pharmacist participating in clinical pathway treating capillary bronchitis. Method After formulating the way clinical pharmacist participating in clinical pathway, we analyzed the case histories with the first diagnosis of capillary bronchitis retrospectively, compared the using of antibacterial agents, hospitalization expenses, medicine expenses and in hospital days before and after clinical pathway, discussed the way and effect of clinical pharmacist participating in clinical pathway. Result The using of antibacterial agents had statistical difference (P<0.01);the hospitalization expenses, medicine expenses and in hospital days had statistical difference (P<0.05 or P<0.01) before and after clinical pathway, After clinical pathway, the hospitalization expenses, medicine costs and in hospital days were reduced obviously. Conclusion The clinical pharmacist participating in clinical pathway formulating, can standardize drug use for patient, save the hospitalization expenses, medicine costs, short the days in hospital, it had important meaning in economizing the cost of treating, reducing the economic burden to patient.